TCON

TRACON Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $15.0 Million

TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock

TRACON Pharmaceuticals appoints new senior vice president of regulatory affairs and grants inducement equity award

TRACON Pharmaceuticals Announces Appointment of Brenda Marczi, PharmD, as Senior Vice President, Regulatory Affairs, and Granting of Inducement Award

TRACON Pharmaceuticals announces appointment of Ya Huang as executive director of Statistical Programming

TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Programming and Granting of Inducement Award

TRACON Pharmaceuticals announces orphan drug designation for envafolimab in soft tissue sarcoma